Drawing for QWYNTRIA

USPTO serial 79299897

QWYNTRIA

Reg. 6422528Status 700Renewal
Filing date
Oct 28, 2020
Status date
Jul 20, 2021
Registration date
Jul 20, 2021
Examiner
SEVERSON, JUSTIN

Need help with QWYNTRIA?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Deadline: July 20th, 2027

Owner

  • Glaxo Group Limited

    GB

  • Glaxo Group Limited

    GB

  • Glaxo Group Limited

    GB

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccinesACTIVE

Prosecution history

DateCodeEvent
Jul 20, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 23, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Aug 18, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 18, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 18, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 18, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 11, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 25, 2021GPNXNOTIFICATION PROCESSED BY IB
Sep 7, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 7, 2021FIMPFINAL DISPOSITION PROCESSED
Aug 19, 2021GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 20, 2021R.PRREGISTERED-PRINCIPAL REGISTER
May 4, 2021PUBOPUBLISHED FOR OPPOSITION
May 3, 2021GPNXNOTIFICATION PROCESSED BY IB
Apr 14, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 14, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 14, 2021NPUBNOTICE OF PUBLICATION
Mar 30, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2021DOCKASSIGNED TO EXAMINER
Jan 15, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 11, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 17, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Related guidance